EGFR and chronic myelogenous leukemia, BCR-ABL1 positive: Gefitinib reverts the effect of LAMA84− exosomes treatment in CML cell adhesion to HS5 monolayer, thus indicating the involvement of EGFR pathway in the adhesion of leukaemic cells to stromal cells.